Sunny Pharmtech Inc. (6676.TWO)
TWD 21.85
(-0.46%)
TWD 21.85
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 38.1 Million | 26.87 Million | -34.35 Million | -26.04 Million | -117.86 Million |
| Net Income | -63.32 Million | -170.24 Million | -174.79 Million | -101.76 Million | -226.29 Million |
| Depreciation & Amortization | 121.22 Million | 111.69 Million | 104.85 Million | 105.62 Million | 97.41 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 12.63 Million | 13.07 Million | 4.17 Million | - | 2.21 Million |
| Change in working capital | -33.24 Million | 75.91 Million | 30.82 Million | -36.11 Million | -25.4 Million |
| Other non-cash items | 5.51 Million | 3.2 Million | 5.83 Million | 5.37 Million | 34.2 Million |
| Investing Cash Flow | -85.85 Million | -221.62 Million | -213.79 Million | -28.58 Million | -108.96 Million |
| Investments in PPE | -145.19 Million | -195.29 Million | -160.52 Million | -68.82 Million | -78.85 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | 48.27 Million | -36 Million | -53.58 Million | 39.58 Million | - |
| Sales/Maturities of investments | 11.41 Million | 4.86 Million | - | - | - |
| Other Investing Activities | -345 Thousand | 4.8 Million | 313 Thousand | 657 Thousand | -30.1 Million |
| Financing Cash Flow | 95.67 Million | 188.37 Million | 235.42 Million | 1.6 Million | 372.16 Million |
| Debt repayment | -181.67 Million | -192.14 Million | -14.95 Million | -4.2 Million | -11.93 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 281.31 Million | - | 252.7 Million | - | - |
| Other Financing Activities | 91.31 Million | -439 Thousand | 439 Thousand | 12.61 Million | 384.1 Million |
| Accounts receivables | -27.58 Million | 34.86 Million | -24.44 Million | 9.35 Million | 65.34 Million |
| Accounts payables | 13.79 Million | - | - | - | - |
| Inventory | -25.1 Million | 25.65 Million | 42.78 Million | -28.95 Million | -84.16 Million |
| Other working capital | -5.4 Million | 13.31 Million | 2.28 Million | -6.79 Million | -6.58 Million |
| Cash at beginning of period | 222.63 Million | 229 Million | 241.71 Million | 294.74 Million | 149.4 Million |
| Cash at end of period | 270.55 Million | 222.63 Million | 229 Million | 241.71 Million | 294.74 Million |
| Capital Expenditure | -145.19 Million | -195.29 Million | -160.52 Million | -68.82 Million | -78.85 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 47.92 Million | -6.36 Million | -12.71 Million | -53.02 Million | 145.33 Million |
| Free Cash Flow | -107.09 Million | -168.41 Million | -194.87 Million | -94.87 Million | -196.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -19.64 Million | -19.64 Million | -5.59 Million | -63.32 Million | -5.59 Million | -26.06 Million |
| Depreciation & Amortization | 30.57 Million | 30.57 Million | 31.11 Million | 121.22 Million | 31.11 Million | 27.89 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 332 Thousand | - | 1.69 Million | 12.63 Million | 1.69 Million | 4.61 Million |
| Change in working capital | -13.08 Million | -13.08 Million | -23.72 Million | -33.24 Million | -23.72 Million | -5.32 Million |
| Other non-cash items | -9.49 Million | -9.16 Million | 2.22 Million | 5.51 Million | 2.22 Million | 12.2 Million |
| Investing Cash Flow | -24.32 Million | -24.32 Million | -26.98 Million | -85.85 Million | -26.98 Million | -15.94 Million |
| Investments in PPE | -11.06 Million | -11.06 Million | -38.56 Million | -145.19 Million | -38.56 Million | -33.42 Million |
| Acquisitions | 75 Thousand | - | - | - | - | - |
| Investment purchases | -25.84 Million | - | - | 48.27 Million | - | - |
| Sales/Maturities of investments | - | - | - | 11.41 Million | - | - |
| Other Investing Activities | -13.25 Million | -13.25 Million | 11.58 Million | -345 Thousand | 11.58 Million | 17.47 Million |
| Financing Cash Flow | -608.5 Thousand | -608.5 Thousand | 36.12 Million | 95.67 Million | 36.12 Million | 11.71 Million |
| Debt repayment | - | - | - | -181.67 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 984 Thousand | - | - | 281.31 Million | - | - |
| Other Financing Activities | -608.5 Thousand | -608.5 Thousand | 36.12 Million | 91.31 Million | 36.12 Million | 11.71 Million |
| Accounts receivables | -15.75 Million | -15.75 Million | -15.95 Million | -27.58 Million | -15.95 Million | 2.16 Million |
| Accounts payables | -11.24 Million | - | - | - | - | - |
| Inventory | 2.25 Million | 2.25 Million | -16.1 Million | -25.1 Million | -16.1 Million | 3.55 Million |
| Other working capital | 405.5 Thousand | 405.5 Thousand | 8.34 Million | -5.4 Million | 8.34 Million | -11.04 Million |
| Cash at beginning of period | 277.55 Million | - | - | 222.63 Million | - | - |
| Cash at end of period | -36.24 Million | -36.24 Million | 14.86 Million | 270.55 Million | 14.86 Million | 9.09 Million |
| Capital Expenditure | -11.06 Million | -11.06 Million | -38.56 Million | -145.19 Million | -38.56 Million | -33.42 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -313.8 Million | -36.24 Million | 14.86 Million | 47.92 Million | 14.86 Million | 9.09 Million |
| Free Cash Flow | -22.38 Million | -22.38 Million | -32.84 Million | -107.09 Million | -32.84 Million | -20.09 Million |
3094
LEGT
RE
BLIN
0610
GMT